Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
SkinHealth Systems
SKIN
$93.1M
| $899K | ﹤0.01% |
670,570
-17,795
| -3% | -$27.1K |
|
2877
First Bank
FRBA
$456M
| $897K | ﹤0.01% |
60,595
+11
| +0% | +$162 |
|
|
CWBC
2878
Community West Bancshares
CWBC
$701M
| $895K | ﹤0.01% |
48,447
+28
| +0.1% | +$525 |
|
2879
NVE Corp
NVEC
$628M
| $892K | ﹤0.01% |
13,991
-1,030
| -7% | -$74K |
|
2880
Fresenius Medical Care
FMS
$12.9B
| $889K | ﹤0.01% |
35,696
+4,622
| +15% | +$110K |
|
2881
Vanguard Consumer Staples ETF
VDC
$7.99B
| $883K | ﹤0.01% |
4,037
-252
| -6% | -$54.5K |
|
|
GPGI
2882
GPGI Inc
GPGI
$4.45B
| $882K | ﹤0.01% |
81,165
-12,597
| -13% | -$155K |
|
2883
Enanta Pharmaceuticals
ENTA
$389M
| $882K | ﹤0.01% |
159,801
+4,974
| +3% | +$30.7K |
|
|
NVMI
2884
Nova
NVMI
$12.4B
| $878K | ﹤0.01% |
+4,764
| New | +$1.1M |
|
2885
Lightwave Logic
LWLG
$1.19B
| $878K | ﹤0.01% |
856,387
-175,126
| -17% | -$273K |
|
2886
Farmers & Merchants Bancorp
FMAO
$469M
| $874K | ﹤0.01% |
36,557
| – | – |
|
2887
Donegal Group Class A
DGICA
$735M
| $874K | ﹤0.01% |
44,525
+33
| +0.1% | +$536 |
|
2888
Star Holdings Shares of Beneficial Interest
STHO
$113M
| $869K | ﹤0.01% |
102,123
-1,992
| -2% | -$17.4K |
|
2889
Lyell Immunopharma
LYEL
$370M
| $863K | ﹤0.01% |
80,234
-2,055
| -2% | -$25.2K |
|
2890
Gyre Therapeutics
GYRE
$711M
| $860K | ﹤0.01% |
111,416
-3,150
| -3% | -$34.5K |
|
2891
Citizens & Northern Corp
CZNC
$446M
| $859K | ﹤0.01% |
42,672
+1,547
| +4% | +$31.5K |
|
2892
BigBear.ai
BBAI
$1.45B
| $854K | ﹤0.01% |
298,607
+11
| +0% | +$52 |
|
2893
eGain
EGAN
$201M
| $853K | ﹤0.01% |
175,893
-61,998
| -26% | -$351K |
|
2894
American Coastal Insurance
ACIC
$492M
| $850K | ﹤0.01% |
73,495
+121
| +0.2% | +$1.47K |
|
2895
Civista Bancshares
CIVB
$598M
| $844K | ﹤0.01% |
43,175
+8
| +0% | +$164 |
|
2896
Vishay Precision Group
VPG
$952M
| $842K | ﹤0.01% |
34,933
+1,411
| +4% | +$33K |
|
|
SSBK
2897
DELISTED
Southern States Bancshares
SSBK
| $841K | ﹤0.01% |
23,526
+904
| +4% | +$29.5K |
|
2898
Limoneira
LMNR
$251M
| $840K | ﹤0.01% |
47,387
+1
| +0% | +$22 |
|
2899
Blink Charging
BLNK
$80.5M
| $838K | ﹤0.01% |
913,390
-22,476
| -2% | -$26K |
|
2900
Bowman Consulting
BWMN
$480M
| $838K | ﹤0.01% |
38,365
-1,674
| -4% | -$39K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.